News Releases
FDA approves remdesivir for COVID-19 patients
October 23, 2020
SAN ANTONIO (Oct. 23, 2020) — The U.S. Food and Drug Administration announced Oct. 22 that the drug remdesivir (Veklury) is the first approved treatment for COVID-19. The antiviral medication has been tested in study sites internationally since February, including a study site led by UT Health San Antonio and its clinical partner, University Health […]
$150,000 gift from Lions Clubs expands eye care at Texas Diabetes Institute
October 23, 2020
Wide-field camera enables testing for diabetic retinopathy over more of the retina. The Lions Clubs International Foundation, in collaboration with South and Central Texas Lions Club members of District 2-A2, have increased their commitment to the prevention of blinding eye diseases with a $150,000 gift to UT Health San Antonio’s Department of Ophthalmology. The gift, […]
UT Health San Antonio’s Liu receives $100,000 grant from The Mary Kay Foundation
October 22, 2020
The Mary Kay Foundation on Oct. 22 announced that UT Health San Antonio is among its 2020 cancer grant recipients. The grants are awarded annually to top accredited research institutions in the United States conducting innovative translational research to better understand cancers that affect women. Zhijie “Jason” Liu, PhD, assistant professor of molecular medicine in […]
UT Health San Antonio researcher receives international grant to study Ewing sarcoma
October 19, 2020
SAN ANTONIO (Oct. 19, 2020) — Although COVID-19 has become the top health and research priority around the world, a child is still diagnosed with cancer every two minutes globally. To meet this urgent need, the Stand Up To Cancer and Cancer Research UK’s Pediatric Cancer New Discoveries Challenge has awarded grants to three international […]
Viral ‘molecular scissor’ is next COVID-19 drug target
October 16, 2020
Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design – blocking a molecular “scissor” that the virus uses for virus production and to disable human proteins crucial to the immune […]
UT Health San Antonio creating national telementoring initiative to improve health care across the U.S.
October 9, 2020
SAN ANTONIO (Oct. 9, 2020) — Thanks to a $3 million grant to UT Health San Antonio, health care workers across rural America may soon have a new way of learning about the latest evidence-based care so that they can provide it to their communities. The grant will help UT Health San Antonio develop a […]